LOKIASV2_0630_ESMFold_hypothetical_protein	4zop-assembly1.cif.gz_B	4zop-assembly1.cif.gz_B Co-crystal Structure of Lipid Kinase PI3K alpha with a selective phosphatidylinositol-3 kinase alpha inhibitor	2.944E+00	0.076	28	28	145	146	87	204	240	121	0.808	0.492
LOKIASV2_0630_ESMFold_hypothetical_protein	8tdu-assembly1.cif.gz_B	8tdu-assembly1.cif.gz_B STX-478, a Mutant-Selective, Allosteric Inhibitor bound to PI3Kalpha	4.002E+00	0.063	26	29	145	146	78	195	227	120	0.801	0.520
LOKIASV2_0630_ESMFold_hypothetical_protein	4waf-assembly1.cif.gz_B	4waf-assembly1.cif.gz_B Crystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alpha	4.255E+00	0.057	25	28	145	146	96	213	250	121	0.808	0.472
LOKIASV2_0630_ESMFold_hypothetical_protein	4ayx-assembly1.cif.gz_A	4ayx-assembly1.cif.gz_A STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10 (ROD FORM B)	4.524E+00	0.057	25	35	139	146	143	246	571	106	0.719	0.182
LOKIASV2_0630_ESMFold_hypothetical_protein	3hhm-assembly1.cif.gz_B	3hhm-assembly1.cif.gz_B Crystal structure of p110alpha H1047R mutant in complex with niSH2 of p85alpha and the drug wortmannin	6.149E+00	0.040	22	26	145	146	106	222	247	125	0.822	0.474
LOKIASV2_0630_ESMFold_hypothetical_protein	3rqe-assembly1.cif.gz_D	3rqe-assembly1.cif.gz_D Cerebral cavernous malformation 3 (CCM3) in complex with paxillin LD1	4.524E+00	0.034	21	28	139	146	1	129	187	134	0.767	0.690
LOKIASV2_0630_ESMFold_hypothetical_protein	4mu6-assembly1.cif.gz_A	4mu6-assembly1.cif.gz_A Crystal Structure of the N-terminal domain of Effector Protein LegC3 from Legionella pneumophila	8.886E+00	0.024	19	33	145	146	55	165	274	118	0.774	0.405
LOKIASV2_0630_ESMFold_hypothetical_protein	6r1j-assembly1.cif.gz_D-2	6r1j-assembly1.cif.gz_D-2 Structure of the soluble AhlC triple head mutant of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.	9.448E+00	0.020	18	15	144	146	57	192	251	139	0.890	0.542
